Over 30 California Auctions End Tomorrow 09/19 - Bid Now
Over 700 Total Lots Up For Auction at Six Locations - TX 09/20, CA 09/23, NY 09/24, CA 09/27, UT 10/01, MI 10/03

GT Medical Technologies publishes data showing targeted therapy effective for treating recurrences of common brain tumor type

Press releases may be edited for formatting or style | January 03, 2019 Alzheimers/Neurology Rad Oncology Operating Room

Dr. Brachman continued, “We are encouraged by these data in meningiomas and look forward to sharing data on the use of this treatment in other aggressive brain tumor types in the near future.”


About GT Medical Technologies, Inc.
stats
DOTmed text ad

Reveal Mobi Pro now available for sale in the US

Reveal Mobi Pro integrates the Reveal 35C detector with SpectralDR technology into a modern mobile X-ray solution. Mobi Pro allows for simultaneous acquisition of conventional & dual-energy images with a single exposure. Contact us for a demo at no cost.

stats

Driven to overcome the limitations of current treatments for recurrent brain tumors and raise the standard of care, a team of brain tumor specialists joined forces and formed GT Medical Technologies with a purpose to prevent disease progression and improve quality of life for patients with recurrent brain tumors. Extensive clinical expertise informed the design of GammaTile Therapy, and deep medical device experience guides the company. The company is headquartered in Tempe, Arizona.

Back to HCB News

You Must Be Logged In To Post A Comment